Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

Issue of Equity - Correction

29 Nov 2017 16:40

RNS Number : 8982X
CATCo Reinsurance Opps Fund Ltd
29 November 2017
 

THIS RELEASE REPLACES NO. 7652X WHICH WAS ANNOUNCED YESTERDAY.

The number of Ordinary shares was incorrectly reported.

All other details remain unchanged.

 

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL OR TO U.S. PERSONS.

 

CATCo Reinsurance Opportunities Fund Ltd.

 

Result of Equity Issue

 

To: Specialist Fund Segment, London Stock Exchange and Bermuda Stock Exchange

Date: 28 November 2017

 

Following its announcement on 8 November 2017, the Company is pleased to announce that it has received applications and commitments for a total of 543,000,000 new C Shares pursuant to the Initial Placing and Offer at the price of US$1 per share, raising gross proceeds of US$543,000,000. Accordingly applications under the Offer and commitments under the Initial Placing will all be met in full. The Company received commitments for a total of 528,845,098 C Shares through the Initial Placing and applications for a total of 14,154,902 C Shares through the Offer.

 

Application has been made for 543,000,000 C Shares to be issued pursuant to the Initial Placing and Offer to be admitted to trading on the Specialist Fund Segment of the London Stock Exchange. It is expected that Admission will become effective, and dealings will commence, at 8:00am (London time) on 1 December 2017.

 

Following Admission, the number of Ordinary Shares that the Company has in issue will be 391,666,430 and the number of C Shares that the Company has in issue will be 543,000,000. The C Shares carry the right to attend or vote at any general meeting of the Company in the same manner as the Ordinary Shares. Accordingly, the total number of voting rights in the Company will be 934,666,430 and the figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

The Company will instruct Euroclear on or around 1 December 2017 (or as soon as practicable thereafter) to credit the appropriate stock accounts in CREST of the placees and subscribers (on a delivery versus payment basis) with their respective entitlements to Depositary Interests in respect of C Shares. Temporary documents of title will not be issued pending the dispatch by post of definitive certificates for C Shares in certificated form, which is expected to take place in the week commencing 11 December 2017.

 

Tony Belisle, Chief Executive, Markel CATCo Investment Management Ltd., said:

 

"We are delighted with the tremendous support shown by existing and new investors for Markel CATCo's specialised ILS investment opportunity. The fundraise will ensure the Company continues to meet the growing demand from our buyers for our unique reinsurance protections."

 

For further information, please contact:

 

Judith Wynne, General Counsel

Mobile: +44 (0) 7986 205364

Telephone: +1 (441) 493 9005

Email: judith.wynne@markelcatco.com

 

Mark Way, Chief Operating Officer

Mobile: +1 (441) 504 9178

Telephone: +1 (441) 493 900

Email: mark.way@markelcatco.com

  

Numis Securities Limited

Hugh Jonathan / Harry Trueman

Telephone: +44 (0) 20 7260 1000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEPGGAWGUPMGQB
Date   Source Headline
7th Mar 20227:00 amRNSScheme of arrangement -Sanction Hearing & Timeline
28th Feb 20227:00 amRNSScheme of arrangement - Voting deadline 1 March
24th Feb 20227:00 amRNSScheme of arrangement - US Bankruptcy Court
18th Feb 20223:04 pmRNSScheme of arrangement - Notices of Scheme Meetings
17th Feb 20227:00 amRNSScheme of arrangement - Convening Order
14th Feb 20225:31 pmRNSScheme of arrangement - Directions Hearing
11th Feb 20227:00 amRNSScheme of arrangement - Amendment of Undertakings
7th Feb 20227:00 amRNSNet Asset Value(s)
4th Feb 20227:00 amRNSScheme of arrangement - improved terms
23rd Dec 20217:00 amRNSNet Asset Value(s)
13th Dec 20212:00 pmRNSScheme of arrangement - Update
10th Dec 20217:00 amRNSScheme of arrangement - Update
18th Nov 20211:00 pmRNSNet Asset Value(s)
12th Nov 20217:00 amRNSResults of early extended deadline & update
9th Nov 20217:00 amRNSHolding(s) in Company
4th Nov 20215:09 pmRNSScheme of arrangement chapter 15 recognition order
1st Nov 20216:01 pmRNSScheme of arrangement Convening Hearing
28th Oct 202112:09 pmRNSPractice Direction Letter
26th Oct 20213:04 pmRNSCorrection - Scheme of arrangement improved terms
26th Oct 20217:00 amRNSScheme of arrangement and Improved Terms
15th Oct 20217:00 amRNSNet Asset Value(s)
7th Oct 20213:40 pmRNSCommencement of US Chapter 15 Proceedings
1st Oct 20212:59 pmRNSUpdate re government enquiries at Markel CATCo
27th Sep 20217:05 amRNSHalf-year Report
27th Sep 20217:00 amRNSScheme of arrangement
17th Sep 20217:00 amRNSNet Asset Value(s)
9th Sep 20219:00 amRNSHolding(s) in Company
31st Aug 20217:00 amRNSNet Asset Value(s)
21st Jul 20217:00 amRNSNet Asset Value(s)
25th Jun 20217:00 amRNSNet Asset Value(s)
10th Jun 20214:31 pmRNSHolding(s) in Company
4th Jun 20213:27 pmRNSHolding(s) in Company
24th May 20217:00 amRNSNet Asset Value(s)
20th May 20217:00 amRNSHolding(s) in Company
19th May 202111:31 amRNSHolding(s) in Company
13th May 20215:43 pmRNSHolding(s) in Company
12th May 20217:00 amRNSTransaction in Own Shares - Compulsory Redemption
30th Apr 20217:00 amRNSCompulsory Acqn of Shares
28th Apr 20219:02 amRNSHolding(s) in Company
22nd Apr 20211:45 pmRNSResults of AGM
22nd Apr 20217:00 amRNSNet Asset Value(s)
15th Apr 20217:00 amRNSAdditional Side Pocket Releases
24th Mar 20217:00 amRNSNet Asset Value(s)
18th Mar 202111:38 amRNSHolding(s) in Company
16th Mar 20213:56 pmRNSAnnual Financial Report for year ended 31 Dec 2020
9th Mar 202112:39 pmRNSHolding(s) in Company
8th Mar 20211:52 pmRNSHolding(s) in Company
5th Mar 202112:45 pmRNSHolding(s) in Company
25th Feb 20217:00 amRNSNet Asset Value(s)
11th Feb 20211:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.